...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New shares issued?
5
Aug 07, 2018 08:36AM
4
Aug 07, 2018 11:01AM
4
Aug 12, 2018 01:52PM
3
Aug 12, 2018 05:44PM
2
Aug 12, 2018 08:12PM

hummm,,,no matter what,,,either way,,,DM has to go public with ZCC !!! Why are waiting in the wings as a private and inaccessible entity to its existing shareholders and future shareholders???..jmo

3
Aug 13, 2018 08:14PM
4
Aug 14, 2018 05:27AM
5
Aug 14, 2018 01:56PM
5
Aug 14, 2018 09:01PM
2
Aug 15, 2018 02:54PM
3
Aug 15, 2018 09:24PM
Share
New Message
Please login to post a reply